David Lavergne
About
David Lavergne has authored 18 papers that have received a total of 551 indexed citations.
This includes 17 papers in Molecular Biology, 6 papers in Nephrology and 4 papers in Cardiology and Cardiovascular Medicine. The topics of these papers are Amyloidosis: Diagnosis, Treatment, Outcomes (17 papers), Parathyroid Disorders and Treatments (6 papers) and Cardiovascular Function and Risk Factors (4 papers). David Lavergne is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (17 papers), Parathyroid Disorders and Treatments (6 papers) and Cardiovascular Function and Risk Factors (4 papers) and collaborates with scholars based in France, Italy and United States. David Lavergne's co-authors include Arnaud Jaccard, Frank Bridoux, Dania Mohty, Bertrand Arnulf and Giampaolo Merlini and has published in prestigious journals such as Blood, European Heart Journal and Haematologica.
In The Last Decade
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Stéphanie Reynard Breakdown of academic impact, for papers by V. Molkov Breakdown of academic impact, for papers by John C. Sefter Breakdown of academic impact, for papers by Oleg Pishnyak Breakdown of academic impact, for papers by Philip R. Tempest Breakdown of academic impact, for papers by Zubair Jinnah Breakdown of academic impact, for papers by Jean‐Marc Lacombe Breakdown of academic impact, for papers by Richard J. Hayden